These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 12529992

  • 1. 5-aza-2'-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells.
    Yang Q, Shan L, Yoshimura G, Nakamura M, Nakamura Y, Suzuma T, Umemura T, Mori I, Sakurai T, Kakudo K.
    Anticancer Res; 2002; 22(5):2753-6. PubMed ID: 12529992
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM, Pao MM, Jones PA.
    Cancer Res; 1998 Jan 01; 58(1):95-101. PubMed ID: 9426064
    [Abstract] [Full Text] [Related]

  • 3. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.
    Segura-Pacheco B, Trejo-Becerril C, Perez-Cardenas E, Taja-Chayeb L, Mariscal I, Chavez A, Acuña C, Salazar AM, Lizano M, Dueñas-Gonzalez A.
    Clin Cancer Res; 2003 May 01; 9(5):1596-603. PubMed ID: 12738711
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z, Zhang L, Ding F, Li J, Guo M, Li W, Wang Y, Yu Z, Zhan Q, Wu M, Liu Z.
    Cancer Lett; 2005 Dec 18; 230(2):271-83. PubMed ID: 16297713
    [Abstract] [Full Text] [Related]

  • 6. Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells.
    Bovenzi V, Momparler RL.
    Cancer Chemother Pharmacol; 2001 Jul 18; 48(1):71-6. PubMed ID: 11488527
    [Abstract] [Full Text] [Related]

  • 7. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
    Sirchia SM, Ferguson AT, Sironi E, Subramanyan S, Orlandi R, Sukumar S, Sacchi N.
    Oncogene; 2000 Mar 16; 19(12):1556-63. PubMed ID: 10734315
    [Abstract] [Full Text] [Related]

  • 8. DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells.
    Singh KP, Treas J, Tyagi T, Gao W.
    Cancer Lett; 2012 Mar 16; 316(1):62-9. PubMed ID: 22082530
    [Abstract] [Full Text] [Related]

  • 9. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
    Karpf AR, Moore BC, Ririe TO, Jones DA.
    Mol Pharmacol; 2001 Apr 16; 59(4):751-7. PubMed ID: 11259619
    [Abstract] [Full Text] [Related]

  • 10. Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells.
    Chu SH, Ma YB, Feng DF, Zhang H, Qiu JH, Zhu ZA.
    Mol Med Rep; 2012 Jan 16; 5(1):138-41. PubMed ID: 21993522
    [Abstract] [Full Text] [Related]

  • 11. [Relationship between RAR-beta gene expression defect and its methylation].
    Gao YP, Li M, Zhang YY, Wang H, He XH, Wang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul 16; 42(7):472-6. PubMed ID: 17961338
    [Abstract] [Full Text] [Related]

  • 12. DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine.
    Bovenzi V, Lê NL, Côte S, Sinnett D, Momparler LF, Momparler RL.
    Anticancer Drugs; 1999 Jun 16; 10(5):471-6. PubMed ID: 10477167
    [Abstract] [Full Text] [Related]

  • 13. Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line.
    Liu X, Dai X, Wu B.
    Urol Int; 2009 Jun 16; 82(1):108-12. PubMed ID: 19172108
    [Abstract] [Full Text] [Related]

  • 14. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.
    Pulukuri SM, Rao JS.
    Int J Oncol; 2005 Apr 16; 26(4):863-71. PubMed ID: 15753979
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K, Yokosuka O, Chiba T, Hirasawa Y, Tada M, Imazeki F, Kataoka H, Saisho H.
    Cancer Res; 2003 Dec 15; 63(24):8674-9. PubMed ID: 14695180
    [Abstract] [Full Text] [Related]

  • 16. Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.
    Hurtubise A, Momparler RL.
    Cancer Chemother Pharmacol; 2006 Nov 15; 58(5):618-25. PubMed ID: 16783580
    [Abstract] [Full Text] [Related]

  • 17. Re-expression of p16 gene in the myeloma cell line U266 induced by synergy of sodium butyrate and 5-Aza-2'-deoxycytidine.
    Du HL, Ren LM, Chen H, Zhu Y, Qi Y.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov 15; 22(11):981-4. PubMed ID: 12433622
    [Abstract] [Full Text] [Related]

  • 18. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
    McGregor F, Muntoni A, Fleming J, Brown J, Felix DH, MacDonald DG, Parkinson EK, Harrison PR.
    Cancer Res; 2002 Aug 15; 62(16):4757-66. PubMed ID: 12183435
    [Abstract] [Full Text] [Related]

  • 19. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
    Keen JC, Yan L, Mack KM, Pettit C, Smith D, Sharma D, Davidson NE.
    Breast Cancer Res Treat; 2003 Oct 15; 81(3):177-86. PubMed ID: 14620913
    [Abstract] [Full Text] [Related]

  • 20. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
    Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS.
    Cancer Res; 2001 Mar 01; 61(5):2320-7. PubMed ID: 11280805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.